Study of INBRX-109 in Conventional Chondrosarcoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions
Conventional Chondrosarcoma
Interventions
DRUG

INBRX-109

Tetravalent DR5 Agonist Antibody

DRUG

Placebo

Placebo

Trial Locations (58)

2050

RECRUITING

Chris O'Brien Lifehouse, Camperdown

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

10021

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10032

ACTIVE_NOT_RECRUITING

Columbia University, New York

10060

RECRUITING

La Fondazione e l'Istituto di Candiolo, Candiolo

13005

RECRUITING

AP-HM - Hôpital de la Timone, Marseille

13125

RECRUITING

Helios Klinikum Berlin-Buch, Berlin

15232

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

21287

RECRUITING

Johns Hopkins, Baltimore

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

27710

RECRUITING

Duke University, Durham

28040

RECRUITING

Hospital Clinico San Carlos, Madrid

RECRUITING

Hospital Fundación Jiménez Díaz, Madrid

32224

RECRUITING

Mayo Clinic - Jacksonville, Jacksonville

33076

RECRUITING

Institut Bergonie, Bordeaux

33612

RECRUITING

Moffitt Cancer Center, Tampa

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

40136

RECRUITING

IRCCS Istituto Ortopedico Rizzoli di Bologna, Bologna

44195

RECRUITING

Cleveland Clinic, Cleveland

46026

RECRUITING

Hospital Universitari i Politecnic La Fe, Valencia

48109

RECRUITING

University of Michigan, Ann Arbor

52242

RECRUITING

University of Iowa, Iowa City

59020

RECRUITING

Centre Oscar Lambret, Lille

59100

RECRUITING

Nuovo Ospedale di Prato, Prato

60611

RECRUITING

Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago

60612

RECRUITING

Rush Cancer Center, Chicago

63110

RECRUITING

Washington University School of Medicine - St. Louis, St Louis

68114

RECRUITING

Nebraska Methodist Hospital, Omaha

68167

RECRUITING

Universitätsmedizin Mannheim, Mannheim

69373

RECRUITING

Centre Leon Berard, Lyon

73104

RECRUITING

University of Oklahoma - Stephenson Cancer Center, Oklahoma City

77030

RECRUITING

MD Anderson Cancer Center, Houston

80220

RECRUITING

University of Colorado, Denver

85054

RECRUITING

Mayo Clinic Cancer Center, Phoenix

90127

RECRUITING

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo

90212

RECRUITING

Precision NextGen Oncology & Research Center, Beverly Hills

90403

RECRUITING

Sarcoma Oncology Center, Santa Monica

94110

RECRUITING

University of California, San Francisco (UCSF), San Francisco

94805

RECRUITING

Gustave Roussy, Villejuif

97201

RECRUITING

Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland

98109

RECRUITING

University of Washington, Seattle

06519

RECRUITING

Yale Cancer Center, New Haven

02114

RECRUITING

Dana Farber Cancer Institute, Boston

RECRUITING

Massachusetts General Hospital, Boston

03766

RECRUITING

Norris Cotton Cancer Center, Lebanon

Unknown

RECRUITING

Princess Alexandra Hospital, Woolloongabba

D04 T6F4

RECRUITING

Saint Vincent's University Hospital part of Irish Sarcoma Group, Dublin

00128

RECRUITING

Policlinico Universitario Campus Biomedico, Roma

9713 GZ

RECRUITING

Groningen UMC, Groningen

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

08035

RECRUITING

Hospital Universitario Vall d'Hebron, Barcelona

08041

RECRUITING

Hospital de la Santa Creu i Sant Pau Barcelona, Barcelona

NW1 2PG

RECRUITING

University College London Hospital (UCL), London

SW3 6JJ

RECRUITING

Royal Marsden NHS Foundation Trust, London

M20 4BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

OX3 7LJ

RECRUITING

Churchill Hospital, Oxford

Sponsors
All Listed Sponsors
lead

Inhibrx Biosciences, Inc

INDUSTRY